COAI has argued that in India the government has been working to keep telecom networks secure, with reviews of the security policy and the insertion of specific clauses into the licences to prevent any risk to network security.
Amid slowing growth and low interest rates, investors will need to focus on stock-picking, suggests John Remmert.
Those who have recovered from COVID-19 respond faster to the Covishield vaccine and reach high antibody levels, says a study, leading to hopes that they may not need a second dose and therefore help widen India's corona immunisation cover.
India in the last five-seven years did not do as well as it could to push progress.
Taiwanese cellphone maker HTC Corp on Thursday said it will strongly defend itself against the patent infringement lawsuits brought by software giant Apple.
Although large companies like Nestle, Dabur or HUL have been impacted by this slowdown in demand, it was the small, local players that have been hit harder.
'We look forward to providing great customer experiences in India.'
Young IIT engineers have come up with an affordable solution to the wastage of agricultural produce by developing a unique solar-powered cold storage system which works at almost zero running cost.
OXSIGHT, founded in 2016 to create wearable technology devices based on how the brain manages visual information, began conducting trials in India two years ago in partnership with leading eye hospitals and clinics.
In an interaction with former Congress chief Rahul Gandhi on the impact of lockdown on India's economy, Rajiv Bajaj, MD, Bajaj Auto, said India tried to implement a hard lockdown which was still porous and ended up with the worst of both worlds.
Pharma body wants all excisable goods used for R&D purposes should be exempted from central excise duty.
When President Obama lands in New Delhi later this week, this spirit of accommodation must reignite a strategic economic relationship between the two countries.
Veteran industrialist Ratan Tata was conferred the title of "Global Visionary of Sustainable Business and Peace" by the Federation of Indo-Israel Chambers of Commerce (FIICC) for epitomising "unity, peace and sustainability". "Ratan Tata's support toward Israel has been unstinted. His commitment to put India on the global map with dignity and respect has been noted by each and everyone. "A man respected by the business communities of all the three countries - India, Israel and UAE - he epitomises unity, peace and sustainability," the president of the bilateral chamber, Gul Kripalani, said.
Sanjeev Nayyar offers a roster of things to do to see the India of our dreams.
The company is banking on investments lined up for product development and other innovations.
At present, the auto sector accounts for about 60 per cent of India's current machine tool demand.
Meet the new class of Forbes India 30 Under 30.
The company, which has so far invested $2 billion in the country since its entry in 1989, said the investment will be made to strengthen its capability in various strategic areas, including innovation, manufacturing, infrastructure and agriculture.
India's first mRNA platform-based vaccine will remain stable at 2-8 degrees Celsius while Pfizer-BioNTech's vaccine needs minus 70 degrees Celsius and Moderna vaccine can remain stable for six months at minus 20 degrees Celsius, reports Sohini Das.
Bullish on Jaguar Land Rover, top industrialist Ratan Tata has hinted at Tatas manufacturing these marquee brands in India, Eastern Europe and the US.
The prize, worth 40,000 pounds, was announced yesterday night by noted environmentalist and broadcaster, Sir David Attenborough.
Kalashnikov USA announced on Tuesday that it is now selling AK-47 assault rifles and shotguns that have been manufactured at a US factory.
These start-ups are different from the ones that have made it big in India.
.jpg)
Govt says Information Technology Agreement will be beneficial to India only when domestic manufacturing is robust
The vaccine would be first made available to the vulnerable population and eventually, it would be available in the private market for all.
The Valcyte case is vital as it bars incremental innovation and recognises the right of patient groups to oppose patents.
Regulators tighten net on safety grounds.
The letter was the latest sign of US frustration about the business environment in India.
Around 11,500 ingredients have been put on the website for the public opinion.
"For several months, we've been working with President (Donald) Trump's transition and governance teams and leaders in Congress providing information on our many programmes and potential business opportunities-including the proposed sale of F-16 fighter aircraft to India," a Lockheed official said.
Chandrasekaran, who is the co-recipient of this year's USIBC Global Corporate Leadership Award, also said it is possible to have a limited deal between India and the US before the elections there in November if both sides work together to get something done and not try to solve all issues at once.
Petroleum Minister Dharmendra Pradhan was to give away the awards but he could not attend because he was travelling.
Sustained growth only if domestic manufacturing rises
PM Modi proposed a USD one billion line of credit to promote projects that support physical and digital connectivity between India and ASEAN.
The PM said Japan and the Indian diaspora has a big role to play in India's growth story.
IT sector has lots of hope from the Union Budget 2014-15.
Master tailors, textile manufacturers and custom clothiers, however, say the upcoming festive season, reinvention in the form of new collections and digital outreach are salvaging the situation somewhat.
The central government's decision to continue controlling supply of the swine flu drug, oseltamivir, will help the drug innovator, Swiss multinational Hoffmann-La Roche, and its Indian licencee, Hetero Drugs, maintain their effective monopoly in the country, even as the drug lacks patent protection in India, fear domestic industry circles.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances